AkzoNobel Q1 EBITDA Beats Forecast, Stock +5%

AkzoNobel posted Q1 2026 adjusted EBITDA €345 million, surpassing consensus €323 million and expanding margin to 14.5% from 13.7%.
Organic sales fell 1% and reported revenue dropped 9% YoY, hurt by a 5% currency impact and a 3% India divestment loss.
Shares jumped about 5% in early Amsterdam trading as the company reaffirmed full‑year 2026 adjusted EBITDA guidance of at least €1.47 billion.
CEO Greg Poux‑Guillaume said low‑teens percent price hikes will offset high‑teens raw‑material inflation, targeting >16% EBITDA margin and 16‑19% ROI.